Prophylactic and curative antibiotics for infective endocarditis;Antibiotherapie curative et prophylactique des endocardites infectieuses

Annales Francaises d'Anesthesie et de Reanimation

Volumn 17, Issue 3, 1998, Pages 257-272

  Seguin, P ^a   Malledant Y ^a  

^a PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

Author keywords

Antibiotic treatment; Infective endocarditis; Prophylaxis

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CEFAMANDOLE; CEFTRIAXONE; FOSFOMYCIN; FUSIDIC ACID; GENTAMICIN; OXACILLIN; PEFLOXACIN; PENICILLIN G; RIFAMPICIN; VANCOMYCIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; BACTERIAL ENDOCARDITIS; HEART VALVE PROSTHESIS; HOSPITAL INFECTION; HUMAN; REVIEW; STAPHYLOCOCCUS; STREPTOCOCCUS; BACTEREMIA; ECHOCARDIOGRAPHY; ECHOGRAPHY; HEART DISEASE; INFECTION; RISK FACTOR; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS INFECTION; SURVIVAL RATE;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; BACTEREMIA; ECHOCARDIOGRAPHY; ENDOCARDITIS, BACTERIAL; HEART DISEASES; HEART VALVE PROSTHESIS; HUMANS; PROSTHESIS-RELATED INFECTIONS; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; STREPTOCOCCAL INFECTIONS; SURVIVAL RATE;

EID: 0031613354     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0750-7658(98)80010-5     Document Type: Review

References (68)

1. 1 Scheld WM, Sande MA. Endocarditis and intravascular infections. In: Mendell GL, Douglas RG, Bennett JE, eds. Principles and practice of infectious diseases. New York: Churchill Livingstone; 1990. p 670-92
2. 2 Delahaye F, Goulet V, Lacassin F, Ecochard R, Selton-Suty C, Hoen B et al. Characteristics of pinfective endocarditis in France in 1991. A 1-year survey. Eur Heart J 1995 ; 16 : 394-401
3. 3 Bayer AS. Infective endocarditis. Clin Infect Dis 1993 ; 17 : 313-22
4. 4 Sandre RM, Shafran SD. Infective endocarditis: review of 135 cases over 9 years. Clin Infect Dis 1996 ; 22 : 276-86
5. 5 Watanakunakorn C, Burkert T. Infective endocarditis at a large community teaching hospital, 1980-1990. A review of 210 episodes. Medicine 1993 ; 72 : 90-102
6. 6 Durack DT, Lukes AS, Bright DK and the Duke Endocarditis Service. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Am J Med 1994 ; 96 : 200-9
7. 7 Hoen B, Béguinot I, Rabaud C, Jaussaud R, Selton-Suty C, May T et al. The Duke criteria for diagnosing infective endocarditis are specific: analysis of 100 patients with acute fever or fever of unknown origin. Clin Infect Dis 1996 ; 23 : 298-302
8. 8 Bayer AS. Editorial: diagnosis criteria for identifying cases of endocarditis - revisiting the Duke criteria two years later. Clin Infect Dis 1996 ; 23 : 303-4
9. 9 Olaison L, Hogevik H. Comparison of the von Reyn and Duke criteria for the diagnosis of infective endocarditis: a critical analysis of 161 episodes. Scand J Infect Dis 1996 ; 28 : 399-406
10. 10 von Reyn CF, Levy BS, Arbeit RD, Frieland G, Crumpacker CS. Infective endocarditis: an analysis based on strict case definitions. Ann Intern Med 1981 ; 94 : 505-18
11. 11 Carbon C, Cartier F, Etienne J, Voiriot P, Domart Y, Gibert C et al. Endocardites infectieuses de l'adulte. Propositions pour l'antibiothérapie curative. Med Mal Infect 1992 ; 22 Suppl : 370-8
12. 12 Wilson WR, Karchmer AW, Dajani AS, Taubert KA, Bayer A, Kaye D et al. Antibiotic treatment of adults with infective endocarditis due to Streptococci, Enterococci, Staphylococci and HACEK microorganisms. JAMA 1995 ; 274 : 1706-13
13. 13 Hoen B. Antibiothérapie des endocardites infectieuses. Méd Thér 1997 ; 3 : 111-7
14. 14 Durack DT, Phil D. Prevention of infective endocarditis. N Engl J Med 1995 ; 332 : 38-44
15. 15 Dajani AS, Taubert KA, Wilson W, Bolger AF, Bayer A, Ferrieri P et al. Prevention of bacterial endocarditis. Recommandations by the American Heart Association. JAMA 1997 ; 277 : 1794-801
16. e conférence de consensus en thérapeutique anti-infectieuse. Prophylaxie de l'endocardite infectieuse. Med Mal Inf 1992 ; 22 Suppl : 1119-41
17. 17 Mani V, Cartwright K, Dooley J, Swarbrick E, Fairclough P, Oakley C. Antibiotic prophylaxis in gastrointestinal endoscopy: a report by a working party for the British Society of Gastroenterology Endoscopy Committee. Endoscopy 1997 ; 29 : 114-9
18. 18 Delahaye F, Leport C. Prophylaxie de l'endocardite infectieuse. Presse Med 1996 ; 25 : 1923-8
19. 19 Leport C, Horstkotte D, Burckhardt D and the group of experts of the International Society for Chemotherapy. Antibiotic prophylaxis for infective endocarditis from an international group of experts toward a European consensus. Eur Heart J 1995 ; 16 Suppl B : 126-31
20. 20 Karchmer AW, Moellering RC, Maki DG, Swartz MN. Single-antibiotic therapy for streptococcal endocarditis. JAMA 1979 ; 241 : 1801-6
21. 21 Francioli P, Etienne J, Hoigné R, Thys J-P, Gerber A. Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone sodium for 4 weeks. Efficacy and outpatient treatment feasibility. JAMA 1992 ; 267 : 264-7
22. 22 Wilson WR, Thompson RL, Wilkowske CJ, Washington JA, Giuliani ER, Geraci JE. Short-term terapy for streptococcal infective endocarditis. Combined intramuscular administration of penicillin and streptomycin. JAMA 1981 ; 245 : 360-3
23. 23 Francioli P, Ruch W, Stamboulian D and the international infective endocarditis study group. Treatment of streptocococcal endocarditis with a single daily dose of ceftriaxone and netilraicin for 14 days: a prospective multicenter study. Clin Infect Dis 1995 ; 21 : 1406-10
24. 24 Megran DW. Enterococcal endocarditis. Clin Infect Dis 1992 ; 15 : 63-71
25. 25 Whitby S, Pallera A, Schaberg DR, Bronze MS. Infective endocarditis caused by Streptococcus pneumoniae with high-level resistance to penicillin and cephalosporin. Clin Infect Dis 1996 ; 23 : 1176-7
26. 26 Fernandez-Guerrero ML, Arbol F, Verdejo C, Fernandez Roblas R, Soriano F. Treatment of experimental endocarditis due to penicillin-resistant Streptococcus pneumoniae. Antimicrob Agents Chemoth 1994 ; 38 : 1103-6
27. 27 Levine DP, Fromm BS, Ramesh Reddy B. Slow response to vancomycin or vancomycin plus rifampicin in methicillin-resistant Staphylococcus aureus endocarditis. Ann Int Med 1991 ; 115 : 674-80
28. 28 Ivert TA, Dismukes WE, Glenn Cobbs C, Blackstone EH, Kirklin JW, Bergdahl LA. Prosthetic valve endocarditis. Circulation 1984 ; 69 : 223-32
29. 29 Calderwood SB, Swinski LA, Waternaux CM, Karchmer AW, Buckley MJ. Risk factors for the development of prosthetic valve endocarditis. Circulation 1985 ; 72 : 31-7
30. 30 Chambers HF, Miller RT, Newman MD. Right-sided Staphylococcus aureus endocarditis in intravenous drug abusers: two-week combination therapy. Ann Int Med 1988 ; 109 : 619-24
31. 31 Ribera E, Gomez-Jimenez J, Cortes E, del Valle O, Planes A, Gonzalez-Alujas T et al. Effectiveness of cloxacillin with and without gentamicin in short-term therapy for right-sided Staphylococcus aureus endocarditis. A randomized, controlled trial. Ann Int Med 1996 ; 125 : 969-74
32. 32 Dworkin RJ, Lee BL, Sande MA, Chambers HF. Treatment of right-sided Staphylococcus aureus endocarditis in intravenous drug users with ciprofloxacin and rifampicin. Lancet 1989 ; 2 : 1071-3
33. 33 Heldman AW, Hartert TV, Ray SC, Daoud EG, Kawalski TE, Pompili VJ et al. Oral antibiotic treatment of right-sided staphylococcal endocarditis in injection drug users: prospective randomized comparison with parenteral therapy. Am J Med 1996 ; 101 : 68-76
34. 34 Gomez-Jimenez J, Ribera E, Almirante B, del Valle O, Pahissa A, Martinez-Vazquez JM. Ciprofloxacin resistance and staphylococcal endocarditis. Lancet 1989 ; 2 : 1525-6
35. 35 Tebas P, Martinez RR, Roman F, Mendaza P, Rodriguez DJ, Daza R et al. Early resistance to rifampicine and ciprofloxacin in the treatment of right-sided Staphylococcus aureus endocarditis. J Infect Dis 1991 ; 163 : 204-5
36. 36 Camus C, Leport C, Raffi F, Michelet C, Cartier F, Vilde JL. Sustained bacteremia in 26 patients with a permanent endocardial pacemaker: assessment of wire removal. Clin Infect Dis 1993 ; 17 : 46-55
37. 37 Klug D, Lacroix D, Savoye C, Goullard L, Grandmougin D, Hennequin JL et al. Systemic infection related to endocarditis on pacemaker leads. Clinical presentation and management. Circulation 1997 ; 95 : 2098-107
38. 38 Berbari EF, Cockerill FR, Steckelberg JM. Infective endocarditis due to unusual or fastidious microorganims. Mayo Clin Proc 1997 ; 72 : 532-42
39. 39 Das M, Badley AD, Cockerill FR, Steckelberg JM, Wilson WR. Infective endocarditis caused by Hacek microorganisms. Ann Rev Med 1997 ; 48 : 25-33
40. 40 Stein A, Raoult D. Q fever endocarditis. Eur Heart J 1995 ; 16 Suppl B : 19-23
41. 41 Solera J, Martinez-Alfaro E, Espinosa A, Recognition and optimum treatment of brucellosis. Drugs 1997 ; 53 : 245-56
42. 42 Akova M, Uzun O, Akalin HE, Hayran M, Unal S, Gur D. Quinolones in treatment of human brucellosis: comparative trial of ofloxacin-rifampicin versus doxycycline-rifampicin. Antimicrob Agents Chemother 1993 ; 37 : 1831-4
43. 43 Tompkins LC, Roessler BJ, Redd SC, Markowitz LE, Cohen ML. Legionella prosthetic-valve endocarditis. N Engl J Med 1988 ; 318 : 530-5
44. 44 Wall TC, Peyton RB, Corey GR. Gonococcal endocarditis: a new look at an old disease. Medicine 1989 ; 68 : 375-80
45. 45 Weiss PJ, Kennedy CA, McCann DF, Hill HE, Oldfield EC. Fulminant endocarditis due to infection with penicillinase-producing Neisseria gonorrhoeae. Sex Trans Dis 1992 ; 19 : 288-90
46. 46 Raoult D, Founder PE, Drancourt M, Marrie TJ, Etienne J, Cosserat J et al. Diagnosis of 22 new cases of Bartonella endocarditis. Ann Int Med 1996 ; 125 : 646-52
47. 47 Spach DH, Kanter AS, Daniels NA, Nowowiejski DJ, Larson AM, Schimdt RA et al. Bartonella (Rochalimaea) species as a cause of apparent "culture negative" endocarditis. Clin Infect Dis 1995 ; 20 : 1044-7
48. 48 Spyrou N, Anderson M, Foale R. Listeria endocarditis. Current management and patient outcome-world literature review. Heart 1997 ; 77 : 380-3
49. 49 Rubinstein E, Lang R. Fungal endocarditis. Eur Heart J 1995 ; 16 Suppl B : 84-9
50. 50 Nguyen MH, Nguyen ML, Yu LV, Mc Mahon D, Keys TF, Amidi M. Candida prosthetic valve endocarditis: propective study of six cases and review of the literature. Clin Infect Dis 1996 ; 22 : 262-7
51. 51 Gilbert HM, Peters ED, Lang SJ, Hartman BJ. Successful treatment of fungal prosthetic valve endocarditis: case report and review. Clin Infect Dis 1996 ; 22 : 348-54
52. 52 Muehrcke DD, Lytle BW, Cosgrove DM. Surgical and long-term antifungal therapy for fungal prosthetic valve endocarditis. Ann Thorac Surg 1995 ; 60 : 538-43
53. 53 Mansur AJ, Safi J, Markus MRP, Aiello VD, Grinberg M, Pomerantzeff PM. A Late failure of surgical treatment for bio-prosthetic valve endocarditis due to Candida tropicalis. Clin Infect Dis 1996 ; 22 : 380-1
54. 54 Johnston PG, Lee J, Domanski M, Dressler F, Tucker E, Rothenberg M et al. Late recurrent Candida endocarditis. Chest 1991 ; 99 : 1531-3
55. 55 Komshian SV, Tablan OC, Palutke W, Reyes MP. Characteristics of left-sided endocarditis due to Pseudomonas aeruginosa in the Detroit medical center. Rev Infect Dis 1990 ; 12 : 693-702
56. 56 Fichtenbaum CJ, Smith MJ. Treatment of endocarditis due to Pseudomonas aeruginosa with imipenem. Clin Infect Dis 1992 ; 14 : 353-4
57. 57 Fang G, Keys TF, Gentry LO, Harris AA, Rivera N, Getz K et al. Prosthetic valve endocarditis resulting from nosocomial bacteremia. A prospective, multicenter study. Ann Int Med 1993 ; 119 : 560-7
58. 58 Fernandez-Guerrero ML, Verdejo C, Azofra J, de Gordolas M. Hospital-acquired infectious endocarditis not associated with cardiac surgery: an emerging problem. Clin Infect Dis 1995 ; 20 : 16-23
59. 59 Nasser RA, Melgar GR, Longworth DL, Gordon SM. Incidence and risk of developing fungal prosthetic valve endocarditis after nosocomial candidemia. Am J Med 1997 ; 103 : 25-32
60. 60 Hoen B, Selton-Suty C, Lacassin F, Etienne J, Briancon S, Leport C et al. Infective endocarditis in patients with negative blood cultures: analysis of 88 cases from a one-year nationwide survey in France. Clin Infect Dis 1995 ; 20 : 501-6
61. 61 Alsip SG, Blackstone EH, Kirklin JW, Cobbs CG. Indications for cardiac surgery in patients with active infective endocarditis. Am J Med 1985 ; 78 Suppl 6B : 138-48
62. 62 Lacassin F, Hoen B, Leport C, Selton-Suty C, Delahaye F, Goulet V et al. Procedures associated with infective endocarditis in adults. A case control study. Eur Heart J 1995 ; 16 : 1968-74
63. 63 Alsip SG, Blackstone EG, Kirkin JW, Cobbs CG. Indications for cardiac surgery in patients with active infective endocarditis. Am J Med 1985 ; 78 Suppl 6B : 138-48
64. 64 Steckelberg JM, Wilson WR. Risk factors for infective endocarditis. Infect Dis Clin North Am 1993 ; 7 : 9-19
65. 65 Hickey AJ, MacMahon SW, Wilcken DEL. Mitral valve prolapse and bacterial endocarditis: when is antibiotic prophylaxis necessary? Am Heart J 1985 ; 109 : 431-5
66. 66 Marks AR, Choong CY, Sanfilippo AJ, Ferré M, Weyman AE. Identification of high risk and low-risk subgroups of patients with mitral-valve prolapse. N Engl J Med 1989 ; 320 : 1031-6
67. 67 Danchin N, Briançon S, Mathieu P, Dureux JB, Voiriot P, Bairati I et al. Mitral valve prolapse as a risk factor for infective endocarditis. Lancet 1989 ; 1 : 743-5
68. 68 Bender DB, Naidorf IJ, Garvey GJ. Bacterial endocarditis: a consideration for physician and dentist. J Am Den Assoc 1984 ; 109 : 415-20